PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Hydroquinine→

Hydroquinine PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
522-66-7
Molecular formula
C20H26N2O2
Molecular weight
326.44 g/mol
Drug class
Quinoline alkaloidantimalarial-related cinchona derivative
Mechanism of action
A cinchona alkaloid related to quinine. Its pharmacological actions have been described in relation to quinoline antiprotozoal activity, but the therapeutic role of hydroquinine itself is poorly established and must not be inferred directly from quinine.
Indications / reported uses
  • Hydroquinine has historical and jurisdiction-specific use as a quinine-related substance, including older preparations for muscle cramps; it is not a standard contemporary antimalarial or routine therapy.

Sources: https://pubchem.ncbi.nlm.nih.gov/#query=hydroquinine · https://www.ncbi.nlm.nih.gov/mesh/?term=hydroquinine · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Hydroquinine PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Hydroquinine Permitted Daily Exposure (PDE) report (the Hydroquinine PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Hydroquinine Occupational Exposure Limit (OEL) report (the Hydroquinine OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.